{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/NVAX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-16T04:07:48.809Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":6062,"canonical_name":"NOVAVAX INC","cik":"0001000694","uei":null,"lei":null,"duns":null,"ticker":"NVAX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":28},"count":28,"timeline":[{"ts":"2026-08-07","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — NOVAVAX INC — 2026-08-07","url_slug":"/sec/cik-0001000694/schedule-13g/0000093751-26-000510","accession_number":"0000093751-26-000510","importance":55},{"ts":"2026-08-06","kind":"sec.filing","form_type":"10-Q","title":"10-Q — NOVAVAX INC — 2026-08-06","url_slug":"/sec/cik-0001000694/10-q/0001000694-26-000018","accession_number":"0001000694-26-000018","importance":45},{"ts":"2026-08-06","kind":"sec.filing","form_type":"8-K","title":"8-K — NOVAVAX INC — 2026-08-06","url_slug":"/sec/cik-0001000694/8-k/0001000694-26-000019","accession_number":"0001000694-26-000019","importance":35},{"ts":"2026-08-06","kind":"sec.filing","form_type":"S-8","title":"S-8 — NOVAVAX INC — 2026-08-06","url_slug":"/sec/cik-0001000694/s-8/0001104659-26-091965","accession_number":"0001104659-26-091965","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"8-K","title":"8-K — NOVAVAX INC — 2026-06-23","url_slug":"/sec/cik-0001000694/8-k/0001104659-26-076648","accession_number":"0001104659-26-076648","importance":35},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — NOVAVAX INC — 2026-06-23","url_slug":"/sec/cik-0001000694/4/0001104659-26-076927","accession_number":"0001104659-26-076927","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — NOVAVAX INC — 2026-06-23","url_slug":"/sec/cik-0001000694/4/0001104659-26-076928","accession_number":"0001104659-26-076928","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — NOVAVAX INC — 2026-06-23","url_slug":"/sec/cik-0001000694/4/0001104659-26-076930","accession_number":"0001104659-26-076930","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — NOVAVAX INC — 2026-06-23","url_slug":"/sec/cik-0001000694/4/0001104659-26-076922","accession_number":"0001104659-26-076922","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — NOVAVAX INC — 2026-06-23","url_slug":"/sec/cik-0001000694/4/0001104659-26-076923","accession_number":"0001104659-26-076923","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — NOVAVAX INC — 2026-06-23","url_slug":"/sec/cik-0001000694/4/0001104659-26-076924","accession_number":"0001104659-26-076924","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — NOVAVAX INC — 2026-06-23","url_slug":"/sec/cik-0001000694/4/0001104659-26-076925","accession_number":"0001104659-26-076925","importance":30},{"ts":"2026-06-23","kind":"sec.filing","form_type":"4","title":"4 — NOVAVAX INC — 2026-06-23","url_slug":"/sec/cik-0001000694/4/0001104659-26-076926","accession_number":"0001104659-26-076926","importance":30},{"ts":"2026-06-20","kind":"sec.insider.18880","reporter":"Rodgers Richard J","title":null,"shares":18880,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-20","kind":"sec.insider.18880","reporter":"King Rachel K.","title":null,"shares":18880,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-20","kind":"sec.insider.m","reporter":"DOUGLAS RICHARD","title":"","shares":18880,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-20","kind":"sec.insider.m","reporter":"King Rachel K.","title":"","shares":18880,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-20","kind":"sec.insider.m","reporter":"Rodgers Richard J","title":"","shares":18880,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-20","kind":"sec.insider.m","reporter":"Alton Gregg H","title":"","shares":18880,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-20","kind":"sec.insider.m","reporter":"MCGLYNN MARGARET G","title":"","shares":18880,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-20","kind":"sec.insider.m","reporter":"MOTT DAVID M","title":"","shares":18880,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-15","kind":"sec.13dg","reporter":"NOVAVAX INC","shares":14841000,"percent_of_class":9.03,"security_title":"SCHEDULE 13D/A","accession_number":"0001398344-26-009210","excerpt":null,"importance":75},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13D/A","title":"SCHEDULE 13D/A — NOVAVAX INC — 2026-05-15","url_slug":"/sec/cik-0001000694/schedule-13d-a/0001398344-26-009210","accession_number":"0001398344-26-009210","importance":70},{"ts":"2026-04-27","kind":"sec.13dg","reporter":"NOVAVAX INC","shares":6655398,"percent_of_class":4.1,"security_title":"SCHEDULE 13G/A","accession_number":"0000070858-26-000241","excerpt":null,"importance":55},{"ts":"2026-04-27","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — NOVAVAX INC — 2026-04-27","url_slug":"/sec/cik-0001000694/def-14a/0001628280-26-027328","accession_number":"0001628280-26-027328","importance":40},{"ts":"2026-04-27","kind":"sec.filing","form_type":"ARS","title":"ARS — NOVAVAX INC — 2026-04-27","url_slug":"/sec/cik-0001000694/ars/0001104659-26-049137","accession_number":"0001104659-26-049137","importance":30},{"ts":"2026-04-27","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — NOVAVAX INC — 2026-04-27","url_slug":"/sec/cik-0001000694/defa14a/0001628280-26-027330","accession_number":"0001628280-26-027330","importance":30},{"ts":"2026-04-27","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — NOVAVAX INC — 2026-04-27","url_slug":"/sec/cik-0001000694/schedule-13g-a/0000070858-26-000241","accession_number":"0000070858-26-000241","importance":30}]}